HC poser on resale of expired meds

New Delhi: Delhi high court on Friday sought the Centre’s stand on a PIL that claimed rampant sale of expired drugs by chemists who erase the original manufacturing and expiry dates and re-stamp them.

Terming the issue as “serious”, a bench of Chief Justice Rajendra Menon and Justice V K Rao said the authorities must look into the matter, adding that it appeared such activities were “happening in Kolkata and Ahmedabad”, where expired medicines were re-stamped as unexpired and routed to other places via Delhi.

Issuing notice, the court said central authorities have to look into it and sought replies from ministry of health and family welfare and the Drug Controller General of India. It also sought their replies to advocate Amit Sahni’s plea seeking directions to the government to curb sale of such medicines.

Sahni, in his PIL, claimed that the original manufacturing and expiry dates as well as MRP were erased from expired medicines and the drugs were re-stamped as unexpired to sell them.

The plea said “expired medicines sold as unexpired not only affect the health of the person(s), but the same leads to unnecessary financial burden, which does not serve the purpose in any manner”.

  • Related Posts

    Gene Therapy for Cholesterol: Initial Test Results Cheer

    Eli Lilly working on single-dose drug to be administered via IV for long-term gain Mumbai: For millions of heart patients struggling with elevated levels of cholesterol, there is a ray…

    US Biotech Regeneron to launch Global Capability Centre in Hyderabad

    Regeneron Pharmaceuticals, Inc. has announced plans to establish the Regeneron Global Capability Centre (GCC) in Hyderabad, a strategic investment that deepens its global operations and scales business functions to advance…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Gene Therapy for Cholesterol: Initial Test Results Cheer

    Gene Therapy for Cholesterol: Initial Test Results Cheer

    US Biotech Regeneron to launch Global Capability Centre in Hyderabad

    US Biotech Regeneron to launch Global Capability Centre in Hyderabad

    Popped the Pill, Paid the Price to Potentially Fatal Skin Syndrome

    Popped the Pill, Paid the Price to Potentially Fatal Skin Syndrome

    Former Advisor to India’s Union Health Ministry gets Quite a Feather in his Cap

    Former Advisor to India’s Union Health Ministry gets Quite a Feather in his Cap

    Alembic Pharma Secures USFDA Approval for Generic Synthroid Tablets

    Alembic Pharma Secures USFDA Approval for Generic Synthroid Tablets

    STF busts fake meds racket spread across 6 states

    STF busts fake meds racket spread across 6 states